Literature DB >> 22058966

2,4-Dioxo-1-(prop-2-yn-yl)-1,2,3,4-tetra-hydro-pyrimidine-5-carbaldehyde.

Yan He1, Liang-Yan Cui, Xin-Ying Zhang.   

Abstract

In the crystal structure of the title compound, C(8)H(6)N(2)O(3), the mol-ecules are linked by a pairs of inter-molecular N-H⋯O hydrogen bonds, forming inversion dimers. The aldehyde group is in the same plane as the pyrimidine ring [with a maximum deviation of 0.083 (2) Å for the O atom), and the linear propargyl group [C-C-C = 178.99 (19)°] makes a dihedral angle of 74.36 (13)° with the ring.

Entities:  

Year:  2011        PMID: 22058966      PMCID: PMC3200754          DOI: 10.1107/S1600536811032272

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For applications of acyclic pyrimidine nucleosides, see: De Clercq (2009 ▶, 2010a ▶,b ▶); Fan et al. (2011 ▶).

Experimental

Crystal data

C8H6N2O3 M = 178.15 Monoclinic, a = 5.1756 (7) Å b = 8.4877 (12) Å c = 18.565 (3) Å β = 90.611 (2)° V = 815.5 (2) Å3 Z = 4 Mo Kα radiation μ = 0.11 mm−1 T = 296 K 0.41 × 0.37 × 0.25 mm

Data collection

Bruker SMART CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 1997 ▶) T min = 0.955, T max = 0.972 5826 measured reflections 1520 independent reflections 1261 reflections with I > 2σ(I) R int = 0.020

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.123 S = 1.08 1520 reflections 118 parameters H-atom parameters constrained Δρmax = 0.14 e Å−3 Δρmin = −0.23 e Å−3 Data collection: SMART (Bruker, 1997 ▶); cell refinement: SAINT (Bruker, 1997 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811032272/is2760sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811032272/is2760Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811032272/is2760Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C8H6N2O3F(000) = 368
Mr = 178.15Dx = 1.451 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 2188 reflections
a = 5.1756 (7) Åθ = 2.6–26.7°
b = 8.4877 (12) ŵ = 0.11 mm1
c = 18.565 (3) ÅT = 296 K
β = 90.611 (2)°Block, colourless
V = 815.5 (2) Å30.41 × 0.37 × 0.25 mm
Z = 4
Bruker SMART CCD area-detector diffractometer1520 independent reflections
Radiation source: fine-focus sealed tube1261 reflections with I > 2σ(I)
graphiteRint = 0.020
phi and ω scansθmax = 25.5°, θmin = 2.6°
Absorption correction: multi-scan (SADABS; Bruker, 1997)h = −6→6
Tmin = 0.955, Tmax = 0.972k = −10→10
5826 measured reflectionsl = −22→21
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.123H-atom parameters constrained
S = 1.08w = 1/[σ2(Fo2) + (0.0694P)2 + 0.1695P] where P = (Fo2 + 2Fc2)/3
1520 reflections(Δ/σ)max < 0.001
118 parametersΔρmax = 0.14 e Å3
0 restraintsΔρmin = −0.23 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes)are estimated using the full covariance matrix. The cell e.s.d.'s are takeninto account individually in the estimation of e.s.d.'s in distances, anglesand torsion angles; correlations between e.s.d.'s in cell parameters are onlyused when they are defined by crystal symmetry. An approximate (isotropic)treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR andgoodness of fit S are based on F2, conventional R-factors R are basedon F, with F set to zero for negative F2. The threshold expression ofF2 > σ(F2) is used only for calculating R-factors(gt) etc. and isnot relevant to the choice of reflections for refinement. R-factors basedon F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.7042 (3)0.8893 (2)0.44458 (8)0.0374 (4)
C20.5046 (3)0.8128 (2)0.40196 (8)0.0376 (4)
C30.4934 (3)0.84333 (19)0.33033 (8)0.0372 (4)
H30.36310.79590.30310.045*
C40.8652 (3)1.01190 (19)0.33360 (8)0.0368 (4)
C50.3180 (4)0.7061 (2)0.43522 (10)0.0510 (5)
H50.34350.67870.48330.061*
C60.6377 (3)0.9724 (2)0.21870 (8)0.0432 (4)
H6A0.46850.93900.20170.052*
H6B0.65121.08510.21100.052*
C70.8363 (4)0.8923 (2)0.17686 (9)0.0464 (5)
C80.9931 (4)0.8282 (3)0.14242 (11)0.0612 (6)
H81.11750.77730.11510.073*
N10.6616 (2)0.93903 (17)0.29646 (7)0.0370 (4)
N20.8664 (3)0.98582 (16)0.40649 (7)0.0398 (4)
H20.98181.03560.43120.048*
O10.7344 (2)0.87340 (16)0.51012 (6)0.0490 (4)
O21.0262 (2)1.09061 (15)0.30334 (6)0.0472 (4)
O30.1324 (3)0.65141 (19)0.40376 (8)0.0685 (5)
U11U22U33U12U13U23
C10.0360 (8)0.0454 (9)0.0308 (8)0.0027 (7)−0.0031 (6)−0.0023 (7)
C20.0353 (8)0.0442 (9)0.0333 (8)0.0011 (7)−0.0018 (6)−0.0066 (7)
C30.0326 (8)0.0439 (9)0.0350 (8)0.0021 (7)−0.0041 (6)−0.0089 (7)
C40.0365 (8)0.0414 (9)0.0323 (8)0.0027 (7)−0.0036 (7)−0.0023 (7)
C50.0503 (10)0.0600 (11)0.0427 (10)−0.0103 (9)−0.0011 (8)−0.0042 (8)
C60.0451 (10)0.0551 (10)0.0294 (8)0.0008 (8)−0.0085 (7)0.0013 (7)
C70.0533 (11)0.0548 (11)0.0311 (8)−0.0078 (9)−0.0027 (8)−0.0019 (8)
C80.0625 (13)0.0738 (14)0.0474 (11)−0.0033 (11)0.0076 (10)−0.0125 (10)
N10.0366 (7)0.0471 (8)0.0272 (7)0.0016 (6)−0.0044 (5)−0.0029 (6)
N20.0402 (8)0.0494 (8)0.0297 (7)−0.0079 (6)−0.0084 (5)−0.0014 (6)
O10.0500 (7)0.0683 (8)0.0285 (6)−0.0120 (6)−0.0057 (5)0.0017 (5)
O20.0470 (7)0.0566 (8)0.0378 (7)−0.0094 (6)−0.0019 (5)0.0039 (5)
O30.0592 (9)0.0805 (11)0.0658 (10)−0.0216 (7)0.0004 (7)−0.0139 (8)
C1—O11.2325 (19)C5—O31.211 (2)
C1—N21.374 (2)C5—H50.9300
C1—C21.449 (2)C6—C71.462 (3)
C2—C31.356 (2)C6—N11.475 (2)
C2—C51.465 (3)C6—H6A0.9700
C3—N11.351 (2)C6—H6B0.9700
C3—H30.9300C7—C81.173 (3)
C4—O21.211 (2)C8—H80.9300
C4—N21.371 (2)N2—H20.8600
C4—N11.397 (2)
O1—C1—N2120.11 (14)C7—C6—N1112.24 (14)
O1—C1—C2124.91 (15)C7—C6—H6A109.2
N2—C1—C2114.98 (13)N1—C6—H6A109.2
C3—C2—C1118.22 (15)C7—C6—H6B109.2
C3—C2—C5120.68 (15)N1—C6—H6B109.2
C1—C2—C5121.10 (15)H6A—C6—H6B107.9
N1—C3—C2123.42 (14)C8—C7—C6178.99 (19)
N1—C3—H3118.3C7—C8—H8180.0
C2—C3—H3118.3C3—N1—C4121.52 (13)
O2—C4—N2123.44 (14)C3—N1—C6121.56 (13)
O2—C4—N1122.30 (14)C4—N1—C6116.91 (14)
N2—C4—N1114.26 (14)C4—N2—C1127.43 (13)
O3—C5—C2123.80 (18)C4—N2—H2116.3
O3—C5—H5118.1C1—N2—H2116.3
C2—C5—H5118.1
O1—C1—C2—C3179.16 (16)O2—C4—N1—C3175.63 (15)
N2—C1—C2—C3−0.7 (2)N2—C4—N1—C3−4.1 (2)
O1—C1—C2—C5−0.4 (3)O2—C4—N1—C6−4.8 (2)
N2—C1—C2—C5179.81 (15)N2—C4—N1—C6175.44 (14)
C1—C2—C3—N11.3 (2)C7—C6—N1—C3−106.92 (18)
C5—C2—C3—N1−179.19 (15)C7—C6—N1—C473.53 (19)
C3—C2—C5—O3−7.1 (3)O2—C4—N2—C1−174.72 (16)
C1—C2—C5—O3172.38 (18)N1—C4—N2—C15.0 (2)
C2—C3—N1—C41.3 (2)O1—C1—N2—C4177.47 (15)
C2—C3—N1—C6−178.27 (15)C2—C1—N2—C4−2.7 (2)
D—H···AD—HH···AD···AD—H···A
N2—H2···O1i0.861.982.8329 (18)174.
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H2⋯O1i0.861.982.8329 (18)174

Symmetry code: (i) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  The history of antiretrovirals: key discoveries over the past 25 years.

Authors:  Erik De Clercq
Journal:  Rev Med Virol       Date:  2009-09       Impact factor: 6.989

Review 3.  Highlights in the discovery of antiviral drugs: a personal retrospective.

Authors:  Erik De Clercq
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

4.  Tandem reactions leading to bicyclic pyrimidine nucleosides and benzopyran-4-ones.

Authors:  Xuesen Fan; Yangyang Wang; Yingying Qu; Haiyun Xu; Yan He; Xinying Zhang; Jianji Wang
Journal:  J Org Chem       Date:  2011-01-07       Impact factor: 4.354

Review 5.  In search of a selective therapy of viral infections.

Authors:  Erik De Clercq
Journal:  Antiviral Res       Date:  2009-10-21       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.